Acepodia (6976.TWO) has a profit margin of -431519.93%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for 6976.TWO is -431519.93% as of June 2026. That compares with -14737.97% in the prior-year period — down 2827.9% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Acepodia's historical trend and sector peers before judging valuation or financial health.
Over the past year, 6976.TWO's profit margin moved from -14737.97% to -431519.93% — a 2827.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acepodia's valuation or profitability profile.
Against Healthcare companies, 6976.TWO currently prints -431519.93% for profit margin, while the sector average sits near 17.63%. That is roughly 2447953.9% below the sector mean. Large gaps often invite a closer look at Acepodia's growth, margins, and balance sheet.
Profit Margin shows how effectively Acepodia converts resources into returns. At -431519.93%, 6976.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -14737.97% in the prior-year period — down 2827.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 6976.TWO's profit margin (-431519.93%), review year-over-year change from -14737.97%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.